We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$287B
AUM Growth
+$27.6B
Cap. Flow
+$6.59B
Cap. Flow %
2.29%
Top 10 Hldgs %
12.98%
Holding
8,864
New
808
Increased
4,307
Reduced
2,684
Closed
688

Sector Composition

Rank Sector Weight
1 Technology 9.82%
2 Financials 7.38%
3 Healthcare 6.65%
4 Consumer Discretionary 5.46%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WHLM
7826
DELISTED
Wilhelmina International, Inc
WHLM
$2K ﹤0.01%
591
-4
-0.7% -$19
BFIIW
7827
DELISTED
BurgerFi International, Inc. Warrant
BFIIW
$2K ﹤0.01%
10,662
+7,600
+248% +$1.18K
BIMI
7828
DELISTED
BIMI International Medical Inc. Common Stock
BIMI
$2K ﹤0.01%
14
+7
+100% +$1.25K
MMAT
7829
DELISTED
Meta Materials Inc. Common Stock
MMAT
$2K ﹤0.01%
11
-8
-42% -$1.33K
KOIN
7830
DELISTED
Capital Link Global Fintech Leaders ETF
KOIN
$2K ﹤0.01%
+80
New +$2.22K
STAF
7831
DELISTED
Staffing 360 Solutions, Inc. Common Stock (DE)
STAF
$2K ﹤0.01%
4
+2
+100% +$1.1K
TRVN
7832
DELISTED
Trevena, Inc.
TRVN
$2K ﹤0.01%
4
-12
-75% -$6.16K
NBSE
7833
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$2K ﹤0.01%
17
-170
-91% -$19.9K
CCLP
7834
DELISTED
CSI Compressco LP
CCLP
$2K ﹤0.01%
650
-832
-56% -$2.17K
NGE
7835
DELISTED
Global X MSCI Nigeria ETF
NGE
$2K ﹤0.01%
181
-1,780
-91% -$23.3K
CHIK
7836
DELISTED
Global X MSCI China Information Technology ETF
CHIK
$2K ﹤0.01%
110
-1,179
-91% -$21.7K
PCTI
7837
DELISTED
PCTEL, Inc. Common Stock
PCTI
$2K ﹤0.01%
+271
New +$2.25K
LTRPB
7838
DELISTED
Liberty TripAdvisor Holdings, Inc. Series B
LTRPB
$2K ﹤0.01%
243
-1,000
-80% -$7.38K
FRG
7839
DELISTED
Franchise Group, Inc.
FRG
$2K ﹤0.01%
+66
New +$1.13K
BNGOW
7840
DELISTED
Bionano Genomics, Inc. Warrant
BNGOW
$2K ﹤0.01%
+7,300
New +$1.23K
ADILW
7841
DELISTED
Adial Pharmaceuticals Warrant
ADILW
$2K ﹤0.01%
9,502
MAAX
7842
DELISTED
VanEck Muni Allocation ETF
MAAX
$2K ﹤0.01%
97
-272
-74% -$6.96K
APEN
7843
DELISTED
Apollo Endosurgery, Inc.
APEN
$2K ﹤0.01%
544
-600
-52% -$1.74K
SMIT
7844
DELISTED
Schmitt Industries Inc
SMIT
$2K ﹤0.01%
543
-122
-18% -$408
PHCF
7845
DELISTED
Puhui Wealth Investment Management Co., Ltd.
PHCF
$2K ﹤0.01%
173
-44
-20% -$661
AGTC
7846
DELISTED
Applied Genetic Technologies Corporation
AGTC
$2K ﹤0.01%
474
-3,625
-88% -$11.5K
AGBAU
7847
DELISTED
AGBA Acquisition Ltd Unit
AGBAU
$2K ﹤0.01%
199
OBCI
7848
DELISTED
Ocean Bio-Chem Inc
OBCI
$2K ﹤0.01%
+733
New +$2.5K
BDR
7849
DELISTED
Blonder Tongue Laboratories Inc
BDR
$2K ﹤0.01%
2,871
-4,050
-59% -$2.76K
JP
7850
DELISTED
Jupai Holdings Limited American depositary shares, each representing six ordinary shares
JP
$2K ﹤0.01%
1,388
+573
+70% +$1.05K

Similar funds

UBS Group's Q4 2019 Portfolio in Review

As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q4 2019 filing shows 808 new, 4,307 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
  • UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
  • UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
  • UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
  • UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
  • UBS Group opened 808 new positions and closed 688 in Q4 2019.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.